Advanced search
Publication Cover
Cutaneous and Ocular Toxicology Volume 30, 2011 - Issue 4
Submit an article Journal homepage
83
Views
5
CrossRef citations to date
0
Altmetric
Case Reports

Sweet’s syndrome associated with the intake of a selective cyclooxygenase-2 (COX-2) inhibitor

Aristóteles RosmaninhoDermatology Department, Centro Hospitalar do Porto, EPE-HSA, Porto, PortugalCorrespondence[email protected]
,
Inês LoboDermatology Department, Centro Hospitalar do Porto, EPE-HSA, Porto, Portugal
&
Manuela SeloresDermatology Department, Centro Hospitalar do Porto, EPE-HSA, Porto, Portugal
Pages 298-301 | Received 24 Feb 2011, Accepted 04 Apr 2011, Published online: 08 Nov 2011

References

  • Sweet RD. An acute febrile neutrophilic dermatosis. Br J Dermatol 1964;76:349–356.
  • Cohen RP. Sweet’s syndrome—a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis 2007;2:34.
  • Fett DL, Gibson LE, Su WP. Sweet’s syndrome: systemic signs and symptoms and associated disorders. Mayo Clin Proc 1995;70:234–240.
  • Kibbi AG, Zaynoun ST, Kurban AK, Najjar SS. Acute febrile neutrophilic dermatosis (Sweet’s syndrome): case report and review of the literature. Pediatr Dermatol 1985;3:40–44.
  • Cohen PR, Kurzrock R. Sweet’s syndrome and cancer. Clin Dermatol 1993;11:149–157.
  • Su WPD, Liu HNH. Diagnostic criteria for Sweet’s syndrome. Cutis 1986;37:167–174.
  • Arbetter KR, Hubbard KW, Markovic SN, Gibson LE, Phyliky RL. Case of granulocyte colony-stimulating factor-induced Sweet’s syndrome. Am J Hematol 1999;61:126–129.
  • von den Driesch P. Sweet’s syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol 1994;31:535–56; quiz 557.
  • Hommel L, Harms M, Saurat JH. The incidence of Sweet’s syndrome in Geneva. A retrospective study of 29 cases. Dermatology (Basel) 1993;187:303–305.
  • Fitzgerald RL, McBurney EI, Nesbitt LT Jr. Sweet’s syndrome. Int J Dermatol 1996;35:9–15.
  • Rosmaninho A, Machado S, Amorim I, Lobo I, Selores M. Henna tattoo and Sweet’s syndrome: a possible relation. Eur J Dermatol 2009;19:642–643.
  • Cohen PR. Sweet’s syndrome. Orphanet Encyclopedia 2003 http://www.orpha.net/data/patho/GB/uk-Sweet.pdf. Accessed on 25 July 2007.
  • Thibault MJ, Billick RC, Srolovitz H. Minocycline-induced Sweet’s syndrome. J Am Acad Dermatol 1992;27:801–804.
  • Tefany FJ, Georgouras K. A neutrophilic reaction of Sweet’s syndrome type associated with the oral contraceptive. Australas J Dermatol 1991;32:55–59.
  • Walker DC, Cohen PR. Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet’s syndrome. J Am Acad Dermatol 1996;34:918–923.
  • Fye KH, Crowley E, Berger TG, LeBoit PE, Connolly MK. Celecoxib-induced Sweet’s syndrome. J Am Acad Dermatol 2001;45:300–302.
  • Hersh EV, Moore PA, Ross GL. Over-the-counter analgesics and antipyretics: a critical assessment. Clin Ther 2000;22:500–548.
  • Lewis JD, Kimmel SE, Localio AR, Metz DC, Farrar JT, Nessel L et al. Risk of serious upper gastrointestinal toxicity with over-the-counter nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology 2005;129:1865–1874.
  • Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P et al.; Adenoma Prevention with Celecoxib (APC) Study Investigators. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 2005;352:1071–1080.
  • Grover SA, Coupal L, Zowall H. Treating osteoarthritis with cyclooxygenase-2-specific inhibitors: what are the benefits of avoiding blood pressure destabilization? Hypertension 2005;45:92–97.
  • Phelan KM, Mosholder AD, Lu S. Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugs. J Clin Psychiatry 2003;64:1328–1334.
  • Helin-Salmivaara A, Huttunen T, Grönroos JM, Klaukka T, Huupponen R. Risk of serious upper gastrointestinal events with concurrent use of NSAIDs and SSRIs: a case-control study in the general population. Eur J Clin Pharmacol 2007;63:403–408.
  • Chung L, Chakravarty EF, Kearns P, Wang C, Bush TM. Bleeding complications in patients on celecoxib and warfarin. J Clin Pharm Ther 2005;30:471–477.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.